RASSF1 and Wilms tumor: Next, we proceeded to analyse SLIT2 promoter methylation status in 37 Wilms' tumours that had been investigated previously for RASSF1A and CASP8 promoter methylation status (Wagner et al, 2002 and unpublished observations).